Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.4B | 7.0B | 5.9B | 5.8B |
Cost of revenue | 2.7B | 2.9B | 2.6B | 2.3B |
Gross profit | 3.7B | 4.1B | 3.2B | 3.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.1B | 1.2B | 1.1B | 1.0B |
Operating income | 1.3B | 1.6B | 924M | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 243.9M | 234.7M | 218.2M | 207.8M |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 1.6B | 939.4M | 1.2B |
Tax provision | 308.7M | 648.8M | 224.8M | 308.8M |
Net income | 953.4M | 950.8M | 717.7M | 920.7M |
Basic EPS | — | 3.5 | 2.6 | 3.4 |
Diluted EPS | — | 3.5 | 2.6 | 3.4 |
Basic average shares | — | 271.8M | 271.7M | 272.2M |
Diluted average shares | — | 273.4M | 272.7M | 273.0M |
EBITDA | 2.2B | 2.5B | 1.8B | 2.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -5.9M | -5M | -22.2M | 5.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |